Contract facts
FederalMedical Countermeasure Drug Discovery and Development Increment 3 Supporting the US Army Medical Research and Developme… is a federal award for Fa4600 55 Cons Pkp held by National Strategic Research Institute. Estimated value $24.5M ($10.7M obligated). Current period of performance ends Aug 31, 2026 (potential Aug 31, 2028). Place of performance: OFFUTT AFB NE.
Medical countermeasure drug discovery and development increment 3 supporting the us army medical research and development command (usa mrdc) and the defense health agency (dca) seeks to provide the united states government and the department of defen. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Aug 31, 2026 (51 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on FA460023F0086? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNational Strategic Research Institute — $27.9M obligated across 41 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA460023F0086?
FA460023F0086 (Medical countermeasure drug discovery and) is a Fa4600 55 Cons Pkp award with a potential value of $24.5M, currently held by National Strategic Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA4600-23-F-0086?
FA4600-23-F-0086 is the dashed form of PIID FA460023F0086 (Medical countermeasure drug discovery and), held by National Strategic Research Institute. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA460023F0086?
Fa4600 55 Cons Pkp awarded FA460023F0086 to National Strategic Research Institute (potential $24.5M).
Who is the incumbent on FA460023F0086?
National Strategic Research Institute is the incumbent with $27.9M across 41 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.
When does National Strategic Research Institute’s FA460023F0086 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA460023F0086? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.